Urologix Inc. (NSDQ:ULGX) hired an Angeion Corp. (NSDQ:ANGN) veteran as its new CFO.
Brian Smrdel takes over from Rebecca Weber, who will stay on as Urologix’s director of finance, according to a statement from the Minneapolis-based company.
Urologix develops devices to treat benign prostatic hyperplasia, or enlarged prostate. The company’s Targis System delivers microwave energy that heats and destroys enlarged prostate tissue and features a cooling mechanism that protects healthy tissue.
The company recently reported financial information for its 2010 third quarter, which Warren described as "challenging." Revenue grew 8 percent to $3.6 million, while Urologix’s net loss narrowed to $597,000. Warren said the company’s financial results were hurt by "physicians’ concern around the future of Medicare payment rates.”
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!